C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/415 (2006.01) A61P 11/00 (2006.01) A61P 29/00 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01)
Patent
CA 2746354
The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes,particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD
Cette invention concerne des composés de formule (I) : qui sont des inhibiteurs de protéine kinase activée par le mitogène p38, en particulier de sous-types alpha et gamma kinase, et leurs utilisations thérapeutiques ainsi que des de compositions pharmaceutiques utilisées, en particulier pour le traitement de maladies inflammatoires, notamment du poumon tels que les broncho-pneumopathies chroniques obstructives du poumon (BPCO).
Charron Catherine Elisabeth
Ito Kazuhiro
Joly Kevin
King-Underwood John
Murray Peter John
Gowling Lafleur Henderson Llp
Respivert Limited
LandOfFree
P38 map kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P38 map kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P38 map kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1919712